The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Stock picking tips

Fri, 06th Mar 2020 15:39

* Bourses fall in virus worries
* Europe's bank at lowest since 2009

Welcome to the home for real-time coverage of European equity markets brought to you by Reuters
stocks reporters. You can share your thoughts with Thyagaraju Adinarayan
(thyagaraju.adinarayan@tr.com), Joice Alves (joice.alves@tr.com), Julien Ponthus
(julien.ponthus@tr.com) in London.

STOCK PICKING TIPS (1540 GMT)
Here are some stock picking tip from BNP Paribas' Edmund Shing.
"You will find that stocks that are sensitive to bonds, relatively speaking are caught up
better than the market overall. Now the stocks that tend to be more bond sensitive are
defensive, and tend to be located in sectors like healthcare and utilities for instance," he
told us in an interview.
"That is often because they have lots of debt," he adds.
Shing also gives hints on how to pick the best stocks in the coronavirus era, beyond the big
utilities names.
"It's very difficult: One strategy you can employ is looking for companies that are falling
off," he says, if you don't find an explanation - like a profit warning or something
fundamentally wrong - this company may be your pick.
Smaller companies often suffer when there is a big sell-off, because in panic selling
investors rush to take some profits off the table, but "in fact the companies that suffer the
sharpest fall sometimes can be those which have very strong fundamentals, which explain why they
had such good performance before the crisis".
"When fundamentals and valuations are diverging, there is a chance that at some point the
price will shoot up, and prices at some point rejoins fundamentals".
(Joice Alves)
*****


WHAT A RIDE FOR UTILITIES! (1411 GMT)
The sector is losing some ground today, although it's still outperforming the others in the
daily coronavirus sell-off we've been seeing of late in Europe. Year-to-date it has been
a darling among investors surviving the meltdown in markets.


European utilities have delivered a double-digit return so far this year and there is more
to that than the bond yield, DB's James Brand writes. Here is his guess why:
- The turn in earnings cycle and return to growth
- Enthusiasm for ESG
- The coronavirus driven rotation into defensives
"Interestingly our correlation analysis suggests that this could be justified just by the
drop in bond yields. However, our view is that robust medium-term earnings growth and long-term
investment opportunities related to ESG may be better reasons to remain bullish," Brand adds.

(Joice Alves)
*****


CARNAGE! (1323 GMT)
Are markets losing it? Bear market territory is not too far away for many bourses. The
pan-European STOXX 600 index has now fallen close to 16% from record highs. Wall Street
meanwhile is getting ready for a 3.2% drop.
"We think that equities will need more visibility if they are to manage to build a viable
bottom or to be able to tap into the power afforded by a reasonable sense of relief – for
example, as a result of easing in the momentum of new coronavirus cases also outside China,"
Christian Stocker at UniCredit says.




(Thyagaraju Adinarayan)
*****

EUROPE'S BANKS AT LOWEST SINCE 2009 (1110 GMT)
European banks are down close to 4% and have now hit their lowest since 2009 as the
coronavirus scare cuts deeper into global markets.
We're past bear territory with a fall of about 25% since February.
Seems there's a combination of straight recession fears (with all that means in terms of
toxic NPLs quickly building up) and expectations of another ECB cut which would bite hard into
margins again.
Germany's 10-y govt bond yield fell to -0.740%, which is very, very close to its record low
of -0.743 of September 2019.
"The situation of the European banking sector is completely different from what it was in
2009", Jerome Legras, head of research at Axiom Alternative Investments just told us.
"There’s the psychological aspect of hitting the same level but I’m not more worried about
their solvency than I was three weeks ago", he added.
"Profitability is a different story though..."

Take a look:


(Joice Alves and Julien Ponthus)
*****



OPENING SNAPSHOT: NOT THE TIME FOR TRAVEL & LEISURE (0823 GMT)
European bourses open in negative territory as coronavirus fears continue to drag down the
stock market.
The pan European index is on track for its third straight day of declines and
needless to say the travel and leisure space is lagging behind all the other sectors,
down more than 3%.
In terms of single stocks, Italy's Prysmian started the day among the top movers,
down almost 10%, after it warned that core profit will not grow this year, blaming trade
tensions, higher tariffs and the coronavirus outbreak.
Capita's capitulation continues as brokers cut price targets after the company's
update yesterday sent shares down 40%.

(Joice Alves)
*****


STOCKS TO WATCH: INFINEON, AIRBUS, ESSILORLUXOTTICA (0745 GMT)
Futures point to another blow for European bourses with 2% plus declines across the board as
coronavirus anxiety continues to grip investors.
In the corporate world, Infineon in focus after a Bloomberg reported that
Washington recommended Trump to block the German chipmaker's proposed $10 billion deal to buy
Cypress Semiconductor as it poses a security risk.
Airbus shares could take a hit as it got zero orders for February due to
coronavirus, but worth remembering that the recent sell-off has likely priced-in most of the bad
news.
EssilorLuxottica is the other name to watch out for after the company said it
expects is first-half revenues to be slower (I'd let you guess the why here).
Non-virus news: British pharma AstraZeneca seen down 2% after its combination
treatment for a form of bladder cancer failed to meet the main goal.

(Thyagaraju Adinarayan)
*****


ANOTHER DAY, ANOTHER SELL-OFF (0637 GMT)
Stocks are seen opening sharply lower again today on top of yesterday's ugly sell-off that
took bank stocks into bear market territory along with autos, travel & leisure and oil & gas.
The number of global coronavirus cases is fast approaching the 100k mark with fears of a
massive economic damage sending shivers down investors' spine.
Financial spreadbetters IG expect London's FTSE to open 114 points lower at 6,592,
Frankfurt's DAX to open 255 points lower at 11,690 and Paris' CAC to open 116 points lower at
5,246.
"Markets have shifted from pricing temporary China weakness to a more protracted global
event, which will see a good chunk of global GDP go up in smoke," said Stephen Innes, chief
market strategist at AxiCorp.

(Thyagaraju Adinarayan)
*****





(Reporting by Joice Alves, Julien Ponthus and Thyagaraju Adinarayan)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.